U.S. Markets close in 3 hrs 30 mins
  • S&P 500

    4,236.15
    -11.29 (-0.27%)
     
  • Dow 30

    34,246.03
    -233.57 (-0.68%)
     
  • Nasdaq

    14,120.29
    +50.87 (+0.36%)
     
  • Russell 2000

    2,333.30
    -2.51 (-0.11%)
     
  • Crude Oil

    71.45
    +0.54 (+0.76%)
     
  • Gold

    1,865.60
    -14.00 (-0.74%)
     
  • Silver

    28.08
    -0.07 (-0.23%)
     
  • EUR/USD

    1.2130
    +0.0023 (+0.1941%)
     
  • 10-Yr Bond

    1.4960
    +0.0340 (+2.33%)
     
  • Vix

    16.69
    +1.04 (+6.65%)
     
  • GBP/USD

    1.4114
    -0.0003 (-0.0183%)
     
  • USD/JPY

    109.9920
    +0.3570 (+0.3256%)
     
  • BTC-USD

    40,277.50
    +3,332.72 (+9.02%)
     
  • CMC Crypto 200

    1,009.28
    +40.44 (+4.17%)
     
  • FTSE 100

    7,146.68
    +12.62 (+0.18%)
     
  • Nikkei 225

    29,161.80
    +213.07 (+0.74%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLU, KRMD and DDD

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

BELLUS Health Inc. (NASDAQ:BLU)
Class Period: September 5, 2019 - July 5, 2020
Lead Plaintiff Deadline: May 17, 2021

During the class period, BELLUS Health Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: while BLU-5937's "high selectivity" contributed to the drug causing little to no taste alteration in chronic cough patients, that high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company's Phase 2 trial.

Learn about your recoverable losses in BLU: http://www.kleinstocklaw.com/pslra-1/bellus-health-inc-loss-submission-form?id=15824&from=1

Repro Med Systems, Inc. (NASDAQ:KRMD)
Class Period: August 4, 2020 - January 25, 2021
Lead Plaintiff Deadline: May 25, 2021

The KRMD lawsuit alleges that throughout the class period, Repro Med Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) starting in January 2020, Repro Med Systems ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company's net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in KRMD: http://www.kleinstocklaw.com/pslra-1/repro-med-systems-inc-loss-submission-form?id=15824&from=1

3D Systems Corporation (NYSE:DDD)
Class Period: May 6, 2020 - March 1, 2021
Lead Plaintiff Deadline: June 8, 2021

Throughout the class period, 3D Systems Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) 3D Systems lacked proper internal controls over financial reporting; and (2) as a result, 3D Systems' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in DDD: http://www.kleinstocklaw.com/pslra-1/3d-systems-corp-loss-submission-form?id=15824&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/647220/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-BLU-KRMD-and-DDD